Azmeena Amir Hashem, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Azmeena Amir Hashem’s office at (408) 539-1083 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$20,172
Medicare paid this office $20,172 for 44 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 41 | $9,175 | $63 |
| Psychotherapy with evaluation and management visit, 30 minutes | 38 | $7,817 | $51 |
| Return visit (30+ min) | 14 | $1,997 | $105 |
Who their Medicare patients are
44 Original Medicare patients in 2024. Average age 70 · Health risk score 0.89. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: Depression 75% · High blood pressure 52%.
The office billed $39,090, Medicare allowed $28,348 and paid $20,172; for 324 services of 4 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 44 | 324 | 70 | 0.89 | $39,090 | $20,172 |
| 2023 | 42 | 228 | 70 | 1.00 | $26,598 | $10,910 |
| 2016 | 403 | 960 | 81 | 3.05 | $106,380 | $47,358 |
| 2015 | 677 | 2,382 | 80 | 2.93 | $269,225 | $123,493 |
| 2014 | 625 | 2,241 | 80 | 2.63 | $253,070 | $117,266 |
| 2013 | 805 | 2,746 | 81 | 2.37 | $330,657 | $131,645 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 40 | $5,749 | $48 |
| Psychotherapy with evaluation and management visit, 30 minutes | 36 | $4,575 | $44 |
2016: 5 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 271 | $29,287 | $43 |
| Psychiatric diagnostic evaluation with medical services | 103 | $9,738 | $95 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 72 | $5,216 | $47 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 19 | $1,393 | $61 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 23 | $819 | $28 |
2015: 6 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 475 | $77,392 | $44 |
| Psychiatric diagnostic evaluation with medical services | 276 | $25,763 | $93 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 79 | $10,793 | $52 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 64 | $5,032 | $59 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 17 | $1,505 | $89 |
| Psychiatric diagnostic evaluation with medical services | 14 | $1,268 | $91 |
2014: 6 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 426 | $69,146 | $44 |
| Psychiatric diagnostic evaluation with medical services | 232 | $21,709 | $94 |
| Residence visit for established patient with low level of medical decision making, per day at least 30 minutes | 79 | $12,389 | $54 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 101 | $9,083 | $58 |
| Psychiatric diagnostic evaluation with medical services | 20 | $1,874 | $94 |
| Residence visit for established patient with moderate level of medical decision making, per day at least 40 minutes | 14 | $1,099 | $69 |
2013: 9 services
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 290 | $31,003 | $38 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day 20 minutes or more | 312 | $27,359 | $37 |
| Psychiatric diagnostic evaluation with medical services | 187 | $15,889 | $85 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 144 | $13,558 | $50 |
| Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | 106 | $12,428 | $53 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 161 | $12,416 | $49 |
| Psychiatric diagnostic evaluation with medical services | 102 | $8,552 | $84 |
| Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | 60 | $7,385 | $76 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 20 | $1,498 | $75 |
Drugs they prescribed that Part D paid
$81,355
Pharmacies billed $81,355 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 740) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
652 generic and 88 brand-name prescriptions · $81,355 in drug cost · 96 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vraylar | 17 | $23,653 | $1,391 |
| Invega Sustenna | 12 | $6,286 | $524 |
| Trintellix | 12 | $5,778 | $482 |
| Desvenlafaxine Succinate Er | 15 | $2,708 | $181 |
| Divalproex Sodium Er | 19 | $2,268 | $119 |
See all 23 drugs
| Vraylar | 17 | $23,653 | $1,391 |
| Invega Sustenna | 12 | $6,286 | $524 |
| Trintellix | 12 | $5,778 | $482 |
| Desvenlafaxine Succinate Er | 15 | $2,708 | $181 |
| Divalproex Sodium Er | 19 | $2,268 | $119 |
| Quetiapine | 49 | $1,627 | $33 |
| Bupropion Xl | 35 | $1,120 | $32 |
| Buspirone | 54 | $1,120 | $21 |
| Trazodone | 61 | $830 | $14 |
| Lurasidone | 21 | $741 | $35 |
| Lamotrigine | 37 | $676 | $18 |
| Methylphenidate Er | 14 | $581 | $42 |
| Divalproex | 16 | $569 | $36 |
| Sertraline | 55 | $536 | $10 |
| Gabapentin | 19 | $405 | $21 |
| Methylphenidate | 18 | $384 | $21 |
| Fluoxetine | 29 | $335 | $12 |
| Phenelzine Sulfate | 12 | $306 | $26 |
| Levothyroxine | 11 | $223 | $20 |
| Escitalopram | 11 | $215 | $20 |
| Duloxetine | 20 | $208 | $10 |
| Clonazepam | 29 | $89 | $3 |
| Haloperidol | 11 | $30 | $3 |
Year by year
| 2024 | 740 | 63 | 0% (0) | 12% | $81,355 |
| 2023 | 704 | 77 | 0% (0) | 11% | $105,929 |
| 2022 | 888 | 92 | 0% (0) | 7% | $87,645 |
| 2021 | 492 | 34 | 0% (0) | 7% | $45,257 |
| 2020 | 478 | 28 | 0% (0) | 10% | $42,450 |
| 2019 | 232 | 27 | 0% (0) | 13% | $23,457 |
| 2018 | 118 | 17 | 0% (0) | None | $5,439 |
| 2016 | 219 | 61 | 0% (0) | 6% | $6,084 |
| 2015 | 477 | 117 | 0% (0) | 4% | $5,939 |
| 2014 | 594 | 133 | 0% (0) | 6% | $10,750 |
| 2013 | 621 | 142 | 0% (0) | 13% | $12,287 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Vraylar | 13 | $31,176 | $2,398 |
| Trintellix | 12 | $6,047 | $504 |
| Desvenlafaxine Succinate Er | 16 | $2,852 | $178 |
| Divalproex Sodium Er | 22 | $1,870 | $85 |
| Buspirone | 58 | $1,361 | $23 |
| Divalproex | 16 | $1,004 | $63 |
| Quetiapine | 44 | $963 | $22 |
| Methylphenidate | 26 | $857 | $33 |
| Trazodone | 60 | $810 | $13 |
| Duloxetine | 25 | $793 | $32 |
| Aripiprazole | 19 | $683 | $36 |
| Lamotrigine | 31 | $591 | $19 |
| Gabapentin | 15 | $419 | $28 |
| Bupropion Xl | 21 | $407 | $19 |
| Sertraline | 35 | $405 | $12 |
| Risperidone | 25 | $402 | $16 |
| Olanzapine | 16 | $282 | $18 |
| Doxepin | 14 | $237 | $17 |
| Levothyroxine | 12 | $205 | $17 |
| Escitalopram | 14 | $193 | $14 |
| Alprazolam | 12 | $91 | $8 |
| Clonazepam | 14 | $84 | $6 |
| Lorazepam | 13 | $60 | $5 |
2022: 28 drugs
| Belsomra | 11 | $4,646 | $422 |
| Lamotrigine Er | 14 | $4,297 | $307 |
| Desvenlafaxine Succinate Er | 11 | $2,358 | $214 |
| Duloxetine | 25 | $2,348 | $94 |
| Aripiprazole | 34 | $2,298 | $68 |
| Divalproex Sodium Er | 27 | $2,160 | $80 |
| Quetiapine | 64 | $1,726 | $27 |
| Trazodone | 75 | $845 | $11 |
| Gabapentin | 44 | $816 | $19 |
| Buspirone | 45 | $766 | $17 |
| Methylphenidate | 27 | $744 | $28 |
| Dextroamphetamine-Amphetamine | 17 | $656 | $39 |
| Divalproex | 14 | $592 | $42 |
| Bupropion Xl | 14 | $546 | $39 |
| Alprazolam | 43 | $521 | $12 |
| Lamotrigine | 37 | $512 | $14 |
| Lithium Carbonate Er | 13 | $501 | $39 |
| Olanzapine | 31 | $462 | $15 |
| Venlafaxine Hcl Er | 26 | $403 | $15 |
| Doxepin | 13 | $363 | $28 |
| Fluoxetine | 21 | $219 | $10 |
| Hydroxyzine | 11 | $184 | $17 |
| Sertraline | 14 | $182 | $13 |
| Risperidone | 15 | $170 | $11 |
| Escitalopram | 20 | $149 | $7 |
| Clonazepam | 15 | $146 | $10 |
| Lorazepam | 35 | $98 | $3 |
| Lithium Carbonate | 13 | $74 | $6 |
2021: 19 drugs
| Latuda | 14 | $20,787 | $1,485 |
| Lamotrigine Er | 12 | $2,641 | $220 |
| Divalproex Sodium Er | 25 | $1,556 | $62 |
| Gabapentin | 31 | $1,299 | $42 |
| Aripiprazole | 20 | $1,009 | $50 |
| Quetiapine | 38 | $652 | $17 |
| Buspirone | 14 | $642 | $46 |
| Methylphenidate | 14 | $558 | $40 |
| Bupropion Xl | 17 | $473 | $28 |
| Trazodone | 39 | $452 | $12 |
| Fluoxetine | 26 | $286 | $11 |
| Olanzapine | 20 | $274 | $14 |
| Lithium Carbonate Er | 12 | $267 | $22 |
| Venlafaxine Hcl Er | 13 | $267 | $21 |
| Escitalopram | 22 | $159 | $7 |
| Lorazepam | 26 | $122 | $5 |
| Clonazepam | 13 | $117 | $9 |
| Lithium Carbonate | 11 | $74 | $7 |
| Alprazolam | 23 | $65 | $3 |
2020: 19 drugs
| Latuda | 12 | $15,210 | $1,267 |
| Lamotrigine Er | 13 | $3,449 | $265 |
| Buprenorphine-Naloxone | 16 | $3,004 | $188 |
| Divalproex Sodium Er | 21 | $1,357 | $65 |
| Aripiprazole | 23 | $940 | $41 |
| Quetiapine | 34 | $872 | $26 |
| Desvenlafaxine Succinate Er | 11 | $786 | $71 |
| Trazodone | 50 | $552 | $11 |
| Lithium Carbonate Er | 22 | $520 | $24 |
| Venlafaxine Hcl Er | 15 | $259 | $17 |
| Buspirone | 20 | $258 | $13 |
| Olanzapine | 12 | $180 | $15 |
| Divalproex | 15 | $173 | $12 |
| Fluoxetine | 24 | $168 | $7 |
| Lorazepam | 18 | $139 | $8 |
| Clonazepam | 13 | $128 | $10 |
| Promethazine | 11 | $110 | $10 |
| Escitalopram | 12 | $95 | $8 |
| Alprazolam | 16 | $21 | $1 |
2019: 6 drugs
| Divalproex Sodium Er | 14 | $1,233 | $88 |
| Quetiapine | 18 | $586 | $33 |
| Trazodone | 20 | $330 | $16 |
| Buspirone | 12 | $242 | $20 |
| Fluoxetine | 15 | $156 | $10 |
| Escitalopram | 14 | $156 | $11 |
2018: 2 drugs
| Duloxetine | 11 | $417 | $38 |
| Clonazepam | 12 | $76 | $6 |
2016: 5 drugs
| Lorazepam | 86 | $767 | $9 |
| Alprazolam | 61 | $543 | $9 |
| Sertraline | 15 | $174 | $12 |
| Trazodone | 16 | $96 | $6 |
| Clonazepam | 13 | $87 | $7 |
2015: 9 drugs
| Alprazolam | 170 | $1,328 | $8 |
| Venlafaxine Hcl Er | 13 | $1,160 | $89 |
| Lorazepam | 101 | $919 | $9 |
| Sertraline | 38 | $533 | $14 |
| Trazodone | 40 | $296 | $7 |
| Mirtazapine | 22 | $260 | $12 |
| Paroxetine | 14 | $228 | $16 |
| Clonazepam | 24 | $188 | $8 |
| Zolpidem | 13 | $148 | $11 |
2014: 9 drugs
| Quetiapine | 64 | $1,371 | $21 |
| Lorazepam | 140 | $1,285 | $9 |
| Alprazolam | 151 | $1,242 | $8 |
| Sertraline | 49 | $426 | $9 |
| Escitalopram | 26 | $305 | $12 |
| Trazodone | 56 | $281 | $5 |
| Fluoxetine | 12 | $161 | $13 |
| Zolpidem | 16 | $141 | $9 |
| Clonazepam | 23 | $120 | $5 |
2013: 13 drugs
| Cymbalta | 16 | $2,610 | $163 |
| Quetiapine | 55 | $1,604 | $29 |
| Lorazepam | 141 | $1,431 | $10 |
| Alprazolam | 154 | $1,425 | $9 |
| Risperidone | 31 | $800 | $26 |
| Temazepam | 18 | $640 | $36 |
| Zolpidem | 20 | $346 | $17 |
| Sertraline | 40 | $274 | $7 |
| Buspirone | 12 | $235 | $20 |
| Valproic Acid | 12 | $176 | $15 |
| Mirtazapine | 15 | $167 | $11 |
| Trazodone | 28 | $131 | $5 |
| Clonazepam | 17 | $102 | $6 |
Money from drug and device companies
$2,802 in 2025
| 2025 | 12 | 123 | None | $2,802 |
| 2024 | 13 | 117 | None | $2,527 |
| 2023 | 12 | 55 | None | $2,282 |
| 2022 | 13 | 47 | None | $937 |
| 2021 | 6 | 14 | None | $320 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Bausch Health US | Aplenzin | $1,053 | 54 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $410 | 15 payments
|
| Abbvie | Vraylar | $260 | 15 payments
|
| Vanda Pharmaceuticals | Fanapt | $204 | 7 payments
|
| Neurocrine BioSciences | Ingrezza | $184 | 6 payments
|
| Lundbeck | Rexulti | $174 | 7 payments
|
See all 123 published payments
| Neurocrine BioSciences | Meals · 2025-12-13 | Ingrezza | $36 |
| Abbvie | Meals · 2025-12-12 | Vraylar | $7 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-22 | Caplyta | $22 |
| Otsuka America Pharmaceutical | Meals · 2025-11-21 | Rexulti | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-21 | Caplyta | $13 |
| Abbvie | Meals · 2025-11-07 | Vraylar | $20 |
| Bausch Health US | Meals · 2025-11-06 | Aplenzin | $20 |
| Neurocrine BioSciences | Meals · 2025-11-06 | Ingrezza | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-05 | Caplyta | $35 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-31 | Caplyta | $33 |
| Abbvie | Meals · 2025-10-30 | Vraylar | $28 |
| Bausch Health US | Meals · 2025-10-30 | Aplenzin | $24 |
| Axsome Therapeutics | Meals · 2025-10-24 | Auvelity | $32 |
| Teva Pharmaceuticals USA | Meals · 2025-10-24 | Austedo Xr | $35 |
| Bausch Health US | Meals · 2025-10-20 | Aplenzin | $20 |
| Abbvie | Meals · 2025-10-18 | Vraylar | $18 |
| Lundbeck | Meals · 2025-10-18 | Rexulti | $32 |
| Bausch Health US | Meals · 2025-10-13 | Aplenzin | $12 |
| Alkermes | Meals · 2025-10-10 | Lybalvi | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-04 | Caplyta | $29 |
| Vanda Pharmaceuticals | Meals · 2025-10-03 | Fanapt | $33 |
| Bausch Health US | Meals · 2025-09-29 | Aplenzin | $14 |
| Abbvie | Meals · 2025-09-27 | Vraylar | $18 |
| Abbvie | Meals · 2025-09-27 | Vraylar | $11 |
| Bausch Health US | Meals · 2025-09-22 | Aplenzin | $15 |
| Alkermes | Meals · 2025-09-19 | Aristada | $16 |
| Lundbeck | Meals · 2025-09-19 | Rexulti | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-09-12 | Rexulti | $21 |
| Bausch Health US | Meals · 2025-09-10 | Aplenzin | $22 |
| Bausch Health US | Meals · 2025-09-08 | Aplenzin | $14 |
| Abbvie | Meals · 2025-09-06 | Vraylar | $17 |
| Teva Pharmaceuticals USA | Meals · 2025-09-05 | Austedo Xr | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-04 | Caplyta | $34 |
| Bausch Health US | Meals · 2025-08-19 | Aplenzin | $17 |
| Bausch Health US | Meals · 2025-08-19 | Aplenzin | $21 |
| Otsuka America Pharmaceutical | Meals · 2025-08-18 | Rexulti | $35 |
| Bausch Health US | Meals · 2025-08-18 | Aplenzin | $11 |
| Bausch Health US | Meals · 2025-08-18 | Aplenzin | $25 |
| Alkermes | Meals · 2025-08-15 | Lybalvi | $21 |
| Bausch Health US | Meals · 2025-08-12 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-08-12 | Aplenzin | $13 |
| Janssen Pharmaceuticals | Meals · 2025-08-08 | Invega Sustenna | $29 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-08 | Trintellix | $16 |
| Abbvie | Meals · 2025-08-01 | Vraylar | $19 |
| Bausch Health US | Meals · 2025-07-28 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-07-28 | Aplenzin | $21 |
| Bausch Health US | Meals · 2025-07-28 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-07-21 | Aplenzin | $21 |
| Bausch Health US | Meals · 2025-07-21 | Aplenzin | $23 |
| Bausch Health US | Meals · 2025-07-14 | Aplenzin | $23 |
| Bausch Health US | Meals · 2025-07-14 | Aplenzin | $23 |
| Teva Pharmaceuticals USA | Meals · 2025-07-12 | Austedo Xr | $29 |
| Abbvie | Meals · 2025-07-11 | Vraylar | $25 |
| Bausch Health US | Meals · 2025-06-30 | Aplenzin | $21 |
| Lundbeck | Meals · 2025-06-27 | Rexulti | $30 |
| Vanda Pharmaceuticals | Meals · 2025-06-20 | Fanapt | $37 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-20 | Caplyta | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-20 | Caplyta | $5 |
| Bausch Health US | Meals · 2025-06-16 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-06-16 | Aplenzin | $14 |
| Bausch Health US | Meals · 2025-06-16 | Aplenzin | $21 |
| Bausch Health US | Meals · 2025-06-10 | Aplenzin | $23 |
| Bausch Health US | Meals · 2025-06-10 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-06-10 | Aplenzin | $16 |
| Bausch Health US | Meals · 2025-06-10 | Aplenzin | $25 |
| Lundbeck | Meals · 2025-05-31 | Rexulti | $14 |
| Alkermes | Meals · 2025-05-23 | Lybalvi | $24 |
| Vanda Pharmaceuticals | Meals · 2025-05-22 | Fanapt | $24 |
| Bausch Health US | Meals · 2025-05-20 | Aplenzin | $13 |
| Bausch Health US | Meals · 2025-05-20 | Aplenzin | $22 |
| Abbvie | Meals · 2025-05-17 | Vraylar | $7 |
| Neurocrine BioSciences | Meals · 2025-05-17 | Ingrezza | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-16 | Caplyta | $34 |
| Bausch Health US | Meals · 2025-05-12 | Aplenzin | $22 |
| Bausch Health US | Meals · 2025-05-12 | Aplenzin | $22 |
| Axsome Therapeutics | Meals · 2025-05-10 | Auvelity | $33 |
| Otsuka America Pharmaceutical | Meals · 2025-05-09 | Rexulti | $26 |
| Lundbeck | Meals · 2025-04-26 | Rexulti | $28 |
| Abbvie | Meals · 2025-04-25 | Vraylar | $9 |
| Alkermes | Meals · 2025-04-25 | Aristada | $30 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $20 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $2 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $19 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $20 |
| Bausch Health US | Meals · 2025-04-22 | Aplenzin | $2 |
| Bausch Health US | Meals · 2025-04-21 | Aplenzin | $1 |
| Bausch Health US | Meals · 2025-04-21 | Aplenzin | $24 |
| Vanda Pharmaceuticals | Meals · 2025-04-18 | Fanapt | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-18 | Caplyta | $35 |
| Neurocrine BioSciences | Meals · 2025-04-12 | Ingrezza | $25 |
| Bausch Health US | Meals · 2025-04-09 | Aplenzin | $17 |
| Abbvie | Meals · 2025-03-28 | Vraylar | $27 |
| Vanda Pharmaceuticals | Meals · 2025-03-28 | Fanapt | $20 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-28 | Caplyta | $22 |
| Neurocrine BioSciences | Meals · 2025-03-15 | Ingrezza | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-14 | Caplyta | $33 |
| Bausch Health US | Meals · 2025-03-13 | Aplenzin | $19 |
| Bausch Health US | Meals · 2025-03-13 | Aplenzin | $18 |
| Bausch Health US | Meals · 2025-03-13 | Aplenzin | $23 |
| Bausch Health US | Meals · 2025-03-13 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-03-13 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-03-13 | Aplenzin | $23 |
| Abbvie | Meals · 2025-02-28 | Vraylar | $14 |
| Axsome Therapeutics | Meals · 2025-02-28 | Auvelity | $36 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-27 | Caplyta | $27 |
| Lundbeck | Meals · 2025-02-22 | Rexulti | $22 |
| Bausch Health US | Meals · 2025-02-19 | Aplenzin | $24 |
| Vanda Pharmaceuticals | Meals · 2025-02-13 | Fanapt | $23 |
| Bausch Health US | Meals · 2025-02-12 | Aplenzin | $21 |
| Bausch Health US | Meals · 2025-02-12 | Aplenzin | $21 |
| Abbvie | Meals · 2025-02-08 | Vraylar | $12 |
| Janssen Pharmaceuticals | Meals · 2025-02-07 | Spravato | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-07 | Caplyta | $34 |
| Abbvie | Meals · 2025-02-01 | Vraylar | $29 |
| Alkermes | Meals · 2025-02-01 | Aristada | $21 |
| Lundbeck | Meals · 2025-01-24 | Rexulti | $31 |
| Bausch Health US | Meals · 2025-01-23 | Aplenzin | $20 |
| Vanda Pharmaceuticals | Meals · 2025-01-18 | Fanapt | $38 |
| Neurocrine BioSciences | Meals · 2025-01-18 | Ingrezza | $36 |
| Bausch Health US | Meals · 2025-01-14 | Aplenzin | $17 |
| Bausch Health US | Meals · 2025-01-14 | Aplenzin | $25 |
| Bausch Health US | Meals · 2025-01-10 | Aplenzin | $25 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-01-10 | Caplyta | $29 |
See earlier years (2024, 2023, 2022, 2021)
2024: $2,527
| Bausch Health US | Aplenzin | $473 | 30 payments
|
| Alkermes | Aristada | $275 | 11 payments
|
| Janssen Pharmaceuticals | Spravato | $274 | 9 payments
|
| Lundbeck | Rexulti | $256 | 12 payments
|
| Abbvie | Vraylar | $243 | 17 payments
|
| Axsome Therapeutics | Auvelity | $184 | 6 payments
|
| Corium | Azstarys | $175 | 6 payments
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $163 | 8 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $153 | 7 payments
|
| Neurocrine Biosciences | Ingrezza | $143 | 5 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $99 | 3 payments
|
| Vanda Pharmaceuticals | Fanapt | $68 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $21 | 1 payment
|
2023: $2,282
| Neuronetics | Neurostar Tms Therapy System | $1,031 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $279 | 11 payments
|
| Alkermes | Aristada | $225 | 10 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $154 | 7 payments
|
| Lundbeck | Rexulti | $134 | 6 payments
|
| Brainsway USA | None | $123 | 1 payment
|
| Bausch Health US | Aplenzin | $99 | 5 payments
|
| Axsome Therapeutics | Auvelity | $80 | 3 payments
|
| Tris Pharma | Dyanavel Xr | $69 | 3 payments
|
| Abbvie | Vraylar | $52 | 3 payments
|
| Corium | Azstarys | $21 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $14 | 1 payment
|
2022: $937
| Abbvie | Vraylar | $165 | 10 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $148 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $147 | 7 payments
|
| Alkermes | Aristada | $136 | 6 payments
|
| Sunovion Pharmaceuticals | Latuda | $66 | 5 payments
|
| Otsuka America Pharmaceutical | Abilify Maintena | $63 | 3 payments
|
| Lundbeck | Rexulti | $53 | 3 payments
|
| Teva Pharmaceuticals USA | Austedo | $45 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $25 | 1 payment
|
| Corium | Azstarys | $24 | 1 payment
|
| Iti | Caplyta | $24 | 1 payment
|
| Bausch Health US | Aplenzin | $21 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm | $20 | 1 payment
|
2021: $320
| Takeda Pharmaceuticals U.S.A. | Trintellix | $83 | 4 payments
|
| Janssen Pharmaceuticals | Spravato | $80 | 3 payments
|
| AbbVie | Vraylar | $45 | 2 payments
|
| Teva Pharmaceuticals USA | Austedo | $44 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $43 | 2 payments
|
| Iti | Caplyta | $25 | 1 payment
|
Professional record
- NPI
- 1134457112
- Licence
- CA 95005317, MI 4704247772
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 2025 Forest Ave Ste 8, San Jose, CA, 95128
- NPI first listed
- 2009-12-02
- NPI last updated
- 2023-08-25
- NPI record certified
- 2023-08-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5776 Stoneridge Mall Rd Ste 280, Pleasanton, CA, 94588